Daibata M - Search Results

1

Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus.

Sairenji T, Daibata M, Sorli CH, Qvistbäck H, Humphreys RE, Ludvigsson J, Palmer J, Landin-Olsson M, Sundkvist G, Michelsen B, et al. Sairenji T, et al. Among authors: daibata m. Diabetologia. 1991 Jan;34(1):33-9. doi: 10.1007/BF00404022. Diabetologia. 1991. PMID: 1647336

2

Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA.

Daibata M, Humphreys RE, Sairenji T. Daibata M, et al. Virology. 1992 Jun;188(2):916-20. doi: 10.1016/0042-6822(92)90553-2. Virology. 1992. PMID: 1316687

3

Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation.

Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T. Mellinghoff I, et al. Among authors: daibata m. Virology. 1991 Dec;185(2):922-8. doi: 10.1016/0042-6822(91)90574-u. Virology. 1991. PMID: 1660209

4

Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern.

Xu M, Capraro GA, Daibata M, Reyes VE, Humphreys RE. Xu M, et al. Among authors: daibata m. Mol Immunol. 1994 Jul;31(10):723-31. doi: 10.1016/0161-5890(94)90146-5. Mol Immunol. 1994. PMID: 8035834

5

More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release.

Daibata M, Xu M, Humphreys RE, Reyes VE. Daibata M, et al. Mol Immunol. 1994 Mar;31(4):255-60. doi: 10.1016/0161-5890(94)90122-8. Mol Immunol. 1994. PMID: 8139580

6

Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.

Daibata M, Speck SH, Mulder C, Sairenji T. Daibata M, et al. Virology. 1994 Feb;198(2):446-54. doi: 10.1006/viro.1994.1056. Virology. 1994. PMID: 8291228

7

Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.

Daibata M, Sairenji T. Daibata M, et al. Virology. 1993 Oct;196(2):900-4. doi: 10.1006/viro.1993.1555. Virology. 1993. PMID: 8396819

8

Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.

Daibata M, Mellinghoff I, Takagi S, Humphreys RE, Sairenji T. Daibata M, et al. J Immunol. 1991 Jul 1;147(1):292-7. J Immunol. 1991. PMID: 1711079

9

Intracellular localization of tyrosine kinase substrates beneath crosslinked surface immunoglobulins in B cells.

Takagi S, Daibata M, Last TJ, Humphreys RE, Parker DC, Sairenji T. Takagi S, et al. Among authors: daibata m. J Exp Med. 1991 Aug 1;174(2):381-8. doi: 10.1084/jem.174.2.381. J Exp Med. 1991. PMID: 1713251 Free PMC article.

10

Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.

Daibata M, Humphreys RE, Takada K, Sairenji T. Daibata M, et al. J Immunol. 1990 Jun 15;144(12):4788-93. J Immunol. 1990. PMID: 2161880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters